These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling? Vieweg WV; Hasnain M; Howland RH; Hettema JM; Kogut C; Wood MA; Pandurangi AK Am J Med; 2012 Sep; 125(9):859-68. PubMed ID: 22748401 [TBL] [Abstract][Full Text] [Related]
5. [Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time]. Odar-Cederlöf I; Hjelmström P; Jersenius I; Andersson M; Rasmanis G; Bergman U Lakartidningen; 2006 Apr 5-11; 103(14):1112-4. PubMed ID: 16681095 [No Abstract] [Full Text] [Related]
6. The reply. Vieweg WV; Hasnain M; Howland RH Am J Med; 2013 Jun; 126(6):e23. PubMed ID: 23684406 [No Abstract] [Full Text] [Related]
7. [Citalopram and QT prolongation]. Alušík Š; Paluch Z Vnitr Lek; 2018; 63(12):952-956. PubMed ID: 29334745 [TBL] [Abstract][Full Text] [Related]
8. Citalopram, escitalopram, and the QT interval. Med Lett Drugs Ther; 2013 Jul; 55(1421):59. PubMed ID: 23863918 [No Abstract] [Full Text] [Related]
9. A critical evaluation of the cardiac toxicity of citalopram: part 1. Howland RH J Psychosoc Nurs Ment Health Serv; 2011 Nov; 49(11):13-6. PubMed ID: 22007855 [TBL] [Abstract][Full Text] [Related]
10. How much to worry about the FDA warning in the use of citalopram? Wang SM; Pae CU Expert Rev Neurother; 2013 Aug; 13(8):883-6. PubMed ID: 23965162 [TBL] [Abstract][Full Text] [Related]
11. A comparative study of QT prolongation with serotonin reuptake inhibitors. Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276 [TBL] [Abstract][Full Text] [Related]
12. A question about the potential cardiac toxicity of escitalopram. Howland RH J Psychosoc Nurs Ment Health Serv; 2012 Apr; 50(4):17-20. PubMed ID: 22421011 [TBL] [Abstract][Full Text] [Related]
13. Effect of activated charcoal on citalopram-induced QT prolongation. Greene SC; Brooks DE; Lovecchio F Ann Emerg Med; 2008 Jul; 52(1):86-7; author reply 87-8. PubMed ID: 18565387 [No Abstract] [Full Text] [Related]
14. Unintended Consequences of Adjusting Citalopram Prescriptions Following the 2011 FDA Warning. Gerlach LB; Kales HC; Maust DT; Chiang C; Stano C; Choe HM; Zivin K Am J Geriatr Psychiatry; 2017 Apr; 25(4):407-414. PubMed ID: 28012712 [TBL] [Abstract][Full Text] [Related]
15. [Citalopram should not be the first choice]. Bergmark T Lakartidningen; 2006 Apr 26-May 2; 103(17):1342. PubMed ID: 16708865 [No Abstract] [Full Text] [Related]
16. Citalopram--a risk factor for postoperative hyponatraemia. Holland S; Townley S; Summerfield R Anaesthesia; 2003 May; 58(5):491-2. PubMed ID: 12694018 [No Abstract] [Full Text] [Related]
20. The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors. Hussaarts KGAM; Berger FA; Binkhorst L; Oomen-de Hoop E; van Leeuwen RWF; van Alphen RJ; Mathijssen-van Stein D; de Groot NMS; Mathijssen RHJ; van Gelder T Pharm Res; 2019 Dec; 37(1):7. PubMed ID: 31845095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]